Related references
Note: Only part of the references are listed.Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study
Stephanie W. Lo et al.
LANCET INFECTIOUS DISEASES (2019)
Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017
Sheldon L. Kaplan et al.
PEDIATRICS (2019)
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000 June 30, 2016
Godwin Oligbu et al.
EMERGING INFECTIOUS DISEASES (2019)
Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada
Leah J. Ricketson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec
Philippe De Wals et al.
VACCINE (2018)
Impact of a National Guideline on Antibiotic Selection for Hospitalized Pneumonia
Derek J. Williams et al.
PEDIATRICS (2017)
Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
Ilias Galanis et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine
Inci Yildirim et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012
Andrea C. Farnham et al.
JAMA PEDIATRICS (2015)
Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine
Stephen I. Pelton et al.
CLINICAL INFECTIOUS DISEASES (2014)
Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine
Pui-Ying Iroh Tam et al.
PEDIATRICS (2014)
Invasive Pneumococcal Disease Among Children With and Without Sickle Cell Disease in the United States, 1998 to 2009
Amanda B. Payne et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
Sheldon L. Kaplan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children
Sheldon L. Kaplan et al.
PEDIATRICS (2010)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004
Lauri A. Hicks et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
